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Postoperative atrial ﬁbrillation (AF) is the most common arrhythmia following cardiac
surgery with extracorporeal circulation. The pathogenesis of postoperative AF is multifac-
torial. Oxidative stress, caused by the unavoidable ischemia–reperfusion event occurring in
this setting, is a major contributory factor. Reactive oxygen species (ROS)-derived effects
could result in lipid peroxidation, protein carbonylation, or DNA oxidation of cardiac tis-
sue, thus leading to functional and structural myocardial remodeling. The vulnerability of
myocardial tissue to the oxidative challenge is also dependent on the activity of the antiox-
idant system. High ROS levels, overwhelming this system, should result in deleterious
cellular effects, such as the induction of necrosis, apoptosis, or autophagy. Nevertheless,
tissue exposure to low to moderate ROS levels could trigger a survival response with a
trend to reinforce the antioxidant defense system. Administration of n−3 polyunsaturated
fatty acids (PUFA), known to involve a moderate ROS production, is consistent with a
diminished vulnerability to the development of postoperative AF. Accordingly, supplemen-
tation of n−3 PUFA successfully reduced the incidence of postoperative AF after coronary
bypass grafting.This response is due to an up-regulation of antioxidant enzymes, as shown
in experimental models. In turn, non-enzymatic antioxidant reinforcement through vitamin
C administration prior to cardiac surgery has also reduced the postoperative AF incidence.
Therefore, it should be expected that a mixed therapy result in an improvement of the
cardioprotective effect by modulating both components of the antioxidant system. We
present novel available evidence supporting the hypothesis of an effective prevention of
postoperative AF including a two-step therapeutic strategy: n−3 PUFA followed by vitamin
C supplementation to patients scheduled for cardiac surgery with extracorporeal circula-
tion. The present study should encourage the design of clinical trials aimed to test the
efﬁcacy of this strategy to offer new therapeutic opportunities to patients challenged by
ischemia–reperfusion events not solely in heart, but also in other organs such as kidney or
liver in transplantation surgeries.
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INTRODUCTION
Atrial ﬁbrillation (AF) is the most common arrhythmia affect-
ing patients after general thoracic surgery. It is associated with
increased risk of stroke and death and constitutes a substantial use
of healthcare resources, including increased duration of hospital-
ization and hospital costs (Zimmer et al., 2003; Gillespie et al.,
2005, 2006). Together with ﬂutter, it is one of the two most the
common arrhythmias that develop in patients postoperatively fol-
lowing coronary artery bypass graft surgery with extracorporeal
circulation. Age is the only risk factor most consistently identi-
ﬁed as a major independent predictor for the development of
postoperative AF. Among other risk factors even a genetic pre-
disposition is plausible since there is inﬂuence of race (Rader
et al., 2011). Despite the available resources of all the modern
antiarrhythmic drugs for effective prophylaxis and advances in
surgical techniques, the incidence of postoperative AF remains
unchanged, ranging from 15 to 40% (Maisel et al., 2001; Elahi
et al., 2003; Mathew et al., 2004). Postoperative AF is associated
with signiﬁcant morbidity and mortality (Villareal et al., 2004; El-
Chami et al., 2010). Moreover, it has been recognized as a risk
factor for short-term morbidity and decreased long-term survival
(Saxena et al., 2012). It was reported that intensive care unit stay
and hospital stay as well as in-hospital mortality were also signiﬁ-
cantly higher among the patients withAF compared with the sinus
rhythm group (Attaran et al., 2011). The precise pathophysiology
of postoperative AF is unknown, however most of the evidence
suggests it is multifactorial (Alqahtani, 2010). The problem of AF
is now widely appreciated, but the underlying mechanisms that
lead to onset and persistence of arrhythmia have been difﬁcult
to elucidate (Van Wagoner, 2007). It is of interest that despite
the documented clinical impact of postoperative AF, the lack of
mechanistic understanding of its occurrence has contributed in
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part to explain why there are no uniformly accepted treatments
for its prevention. The pathophysiological mechanisms of post-
operative AF are inﬂuenced by preoperative, intraoperative, and
postoperative factors. In on-pump cardiac surgery, the unavoid-
able occurrence of an ischemia–reperfusion event leads to the
formation of reactive oxygen species (ROS), causing oxidative
stress, and a systemic inﬂammatory response (Matata et al., 2000;
Elahi et al., 2008; Van Wagoner, 2008). ROS react with cell mol-
ecules such as lipids, proteins, and nucleic acids, leading to alter-
ations of a variety of metabolic pathways and abnormal function
of cellular structures and macromolecules. Thus, ROS-mediated
oxidative damage of cardiomyocyte is characterized by processes
such as lipid peroxidation, protein carbonylation and/or nitration,
DNA oxidation, among others, accounting for structural modiﬁ-
cations in cardiac tissue. Accumulating evidence suggests a link
between AF and myocardial oxidative processes, since the latter
may contribute to atrial remodeling (Korantzopoulos et al., 2003;
Van Wagoner, 2003). These changes are associated with break-
down of cell membrane, impairment of mitochondrial function,
calcium overload, and apoptosis. In turn, there has been emerg-
ing data to support the association between inﬂammation and
AF (Boos et al., 2006). Oxidative stress triggers proinﬂammatory
signaling pathways that activate nuclear factor kappaB (NF-κB)
and AP-1 transcription factors (Bowie and O’Neill, 2000). The
deleterious consequences of high ROS exposure, such as inﬂam-
mation,cell death (apoptosis/autophagy/necrosis),or ﬁbrosis,may
be abrogated by myocardial preconditioning caused by previ-
ous exposure to moderate ROS concentration known to trigger
survival response mechanisms (Fruehauf and Meyskens, 2007).
Marked inﬂammatory inﬁltrates, myocyte necrosis, and ﬁbrosis
have been demonstrated in the atrial biopsies of patients with
lone AF refractory to antiarrhythmic drug therapy, but not in
control patients (Frustaci et al., 1997). Consequently, the struc-
tural cardiomyocyte alterations may give rise to aberrations in
impulse generation, propagation, or the duration and conﬁgura-
tion of individual cardiac action potentials, thus accounting for
the basis of disorders of cardiac rhythm. The Na+ channel plays
a central role in the generation of sinus rhythm and its alteration
is associated with AF (Grant, 2001; Olson et al., 2005). Therefore,
the myocardial oxidative injury can lead to increased susceptibil-
ity to postoperative AF. On the basis of this paradigm, it should
be expected that a reinforcement of the antioxidant defense sys-
tem, prior to the oxidative challenge, results in a cardioprotective
effect expressed by a decreased incidence of postoperative AF. Up
to date, to our knowledge, the largely empirical prophylactic ther-
apies have not taken into account this point of view. This study
presents the molecular basis to achieve a decreased vulnerability of
myocardial tissue to the oxidative challenge created by its exposure
to the ischemia–reperfusion occurring during cardiac surgerywith
extracorporeal circulation (on-pump). The novel pharmacologi-
cal design is based on a two-step strategy aimed to exert a positive
modulation of the antioxidant system.
IMPLICATIONS OF OXIDATIVE STRESS FOR HEART DISEASE
GENERAL ASPECTS OF OXIDATIVE STRESS
Oxidative stress constitutes a unifying mechanism of injury of
many types of disease processes (Rodrigo, 2009), it occurs when
there is an imbalance between the generation of ROS and the
antioxidant defense systems in the body so that the latter become
overwhelmed (Juránek and Bezek, 2005). In the cellular metab-
olism, the oxygen molecule itself is reduced to water after form-
ing, as successive intermediates, superoxide, hydrogen peroxide
(H2O2), and hydroxyl radical. It is estimated that between 0.15
and 2% of cellular O2 consumption results in superoxide for-
mation (Tahara et al., 2009). In turn, RNS mainly include nitric
oxide (NO), peroxynitrite anion (ONOO−) that is the product of
the reaction between NO and superoxide, and nitrogen dioxide
radical (NOO·) formed during the homolytic decomposition of
peroxynitrous acid. Ischemic heart disease is perhaps the human
condition in which the role of oxidative stress has been investi-
gated in more detail. There is major evidence on the contribution
of oxidative stress to myocardial damage in clinical settings related
to ischemia–reperfusion events, such as acute myocardial infarc-
tion, percutaneous coronary interventions following myocardial
infarction or postoperative AF, among others. ROS and RNS and
consequent expression of oxidative damage have been demon-
strated both in ischemia and during post-ischemic reperfusion in
humans. However, they may also participate as important signal-
ing species in the normal physiology of healthy cells. Moreover,
available evidence suggests that these molecules can trigger defen-
sivemechanisms essential for cell survival. The role of intermediate
metabolism during myocardial ischemia together with the cel-
lular redox state might represent a promising interpretative key
(Ceconi et al., 2003). The mitochondrial electron transport chain
is involved in oxygen sensing and would therefore need to respond
to changes in oxygen levels (Debreceni and Debreceni, 2011).
ROS SOURCES
Cardiac myocytes are able to generate ROS in a variety of ways.
The greatest ROS source is from electrons lost during transfer
between electron transport chain complexes in mitochondrial
oxidative phosphorylation processes. Mitochondrial ROS are pro-
duced during oxidative metabolism through the one electron
reduction of oxygen (O2) to form superoxide; the mitochondr-
ial electron transport chain generates superoxide predominantly
at complexes I and III (Murphy, 2009). In addition, ROS can be
generated from enzymes, such as NADPH oxidase (from heart and
phagocytes), uncoupled endothelial nitric oxide synthase (eNOS),
xanthine oxidase (XO), and lipoxygenase/cyclooxygenase, aside
from the oxidation of catecholamines. NADPH oxidase activity
occurs in cardiomyocytes and heart endothelial cells. Further-
more, the phagocytic NADPH oxidase NOX2 (gp91) produces
superoxide anions by reducing O2 (Brown and Griendling, 2009);
local non-phagocytic NADPH oxidases have been implicated in
ROS production following growth factor and cytokine stimula-
tion (Ushio-Fukai, 2009). The cellular effects of ROS are partially
mediated by NF-κB activation. NF-κB mainly exists in the cytosol
as a pre-formed trimeric complex that consists of the inhibitory
protein IκB and the P50/P65 protein dimer. ROS induce redox
changes that result in phosphorylation of IκB subunit, thereby
activating its proteolytic digestion. When the inhibitor subunit is
dislodged from the P60/P65 heterodimer, NF-κB can translocate
to the nucleus, bind DNA, and initiate transcription. In addi-
tion to being a major mediator of cytokine effects in the heart,
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NF-κB regulates cardiac gene expression programs downstream
of multiple signal transduction cascades in a variety of physi-
ological and pathophysiological states. Blocking NF-κB reduces
infarct size in the murine heart after ischemia–reperfusion (Jones
et al., 2003), implicating NF-κB as a major determinant of cell
death in this setting, thus supporting the concept that it may be
an important therapeutic target for speciﬁc cardiovascular disease.
Antioxidants, including vitamin E, can abrogate NF-κB activation.
Oxidation of P50 on its DNA-binding domain has been shown
to act as a protective mechanism by preventing NF-κB binding
(Wang et al., 2011a). Finally, a novel zinc-ﬁnger protein,monocyte
chemoattractant protein-1 (MCP-1)-induced protein (MCPIP), is
thought to have NF-κB inhibitory activity in certain cell cultures,
but its pathophysiological consequence in vivo remains undeﬁned.
Compared with lipopolysaccharide (LPS)-treated wild-type mice,
MCPIP transgenic mice have markedly reduced levels of myocar-
dial inﬂammatory cytokines, less iNOS expression and peroxyni-
trite formation, decreased caspase-3/7 activities, and apoptotic cell
death. This novel protein might protect the heart from inﬂamma-
tory pathologies, possibly through inhibition of the IκB kinase
complex, which prevents NF-κB activation, and attenuates the
proinﬂammatory state and nitrosative stress in the myocardium
(Niu et al., 2011).
ANTIOXIDANT DEFENSES
Enzymatic antioxidant defenses include superoxide dismutase
(SOD), glutathione peroxidase (GSH-Px), and catalase (CAT).
Non-enzymatic antioxidants include a variety of mostly exoge-
nous biological molecules, such as ascorbic acid (vitamin C), α-
tocopherol (vitamin E), reduced glutathione (GSH), carotenoids,
ﬂavonoids, polyphenols, and other exogenous antioxidants (Gas-
paretto et al., 2005). Oxidative stress develops when ROS produc-
tion is sufﬁcient to overwhelm the antioxidant defense system,
which leads to increased ROS and RNS steady-state concentra-
tions thereby damaging biomolecules. Examples of pathophys-
iological cardiac states associated with oxidative stress derived
from ischemia and reperfusion are acute myocardial infarction,
cardiac surgery with extracorporeal circulation and heart trans-
plantation, among others. The vulnerability of myocardial tis-
sue to oxidative challenges caused by reperfusion is dependent
on antioxidant system activity. The ﬁrst line of cellular defense
against oxidative injury include the antioxidant enzymes CAT,
SOD, and GSH-Px. MnSOD overexpression protects the murine
myocardium frompost-ischemic injury; however, neitherGSH-Px
nor Cu/ZnSOD appear to be important determinants of the extent
of myocardial injury in this in vivo model (Jones et al., 2003).
Consistent with this view, it has been reported that infarct size is
markedly reduced in transgenicmice that over-express SOD(Chen
et al., 1998). In contrast, in a tamoxifen-inducible cardiomyocyte-
speciﬁc catalase-over-expressing mouse model, there were no
acute functional improvements with physiological CAT overex-
pression before myocardial infarction. However, hydrogen perox-
ide scavenging reduced proinﬂammatory cytokines and altered
cardiac collagen isoforms, associated with an improvement in car-
diac function after 21 days. These data suggest that sustained rather
than acuteH2O2 levelsmay be relevant in themyocardial remodel-
ing and cardiac function (Pendergrass et al., 2011). Mitochondrial
and cell cytosolic components of the antioxidant system can
neutralize excess mitochondrial ROS under most conditions.
Reactive oxygen species are not just by-products of mitochon-
drial respiration, but also play a key role in cell signaling. Cardiac
tissue exposure to low to moderate ROS levels should trigger a
survival response and reinforce ROS scavengers of the antioxidant
defense system to elicit a cardioprotective effect for myocardial
reperfusion. In fact, the molecular mechanism responsible for this
adaptive change involves enhanced antioxidant activity achieved
by up-regulating several housekeeping genes partly under the con-
trol of nuclear factor erythroid 2-related factor-2 (Nrf2). Nrf2 is
normally sequestered in the cytosol by Kelch-like ECH-associated
protein 1 (Keap1). Upon oxidative stimulation, Nrf2 oxidizes or
covalently modiﬁes Keap1 thiol groups, dissociates from Keap1
and undergoes nuclear translocation. In the nucleus, Nrf2 binds
to antioxidant response elements (ARE) in target gene promoters
(Kobayashi and Yamamoto, 2005), which increase the expression
of antioxidant enzymes. It was demonstrated that the constitu-
tive levels/activities of a number of important antioxidants and
phase 2 enzymes, such as CAT, GSH-Px, glutathione reductase,
glutathione S-transferase, NAD(P)H:quinone oxidoreductase 1,
and heme oxygenase-1 in primary cardiomyocytes are dependent
on Nrf2 status. Therefore, Nrf2 should be expected to contribute
to diminish the susceptibility of cardiomyocytes to injury elicited
by oxidants and electrophilic species (Zhu et al., 2008),making the
Nrf2 signaling pathway an important mechanism for myocardial
cytoprotection.
It is of interest to note that the magnitude of ROS levels could
determine the activation of NF-κB and/or Nrf2 pathways.
PATHOPHYSIOLOGY OF ROS-MEDIATED POSTOPERATIVE ATRIAL
FIBRILLATION
The pathophysiological effects of ROS depend upon the type, con-
centration, and speciﬁc site of production and involve three broad
types of action. A wide mechanistic survey of AF is beyond the
scope of the present review, but it has been previously discussed in
detail (Van Wagoner, 2007). This section is devoted to present the
experimental and clinical evidence to account for the role of ROS
in the pathogenesis of AF following cardiac surgery.
Multiple lines of evidence have strongly suggested a link
between oxidative stress and cardiac arrhythmias, especially AF
(Neuman et al., 2007; Negi et al., 2010). Interestingly, cardiac
surgery has also been reported to increase oxidative stress as
measured by thiol ratios in the plasma and myocardium (De
Vecchi et al., 1998). Moreover, these data suggest that oxidative
stress markers may have predictive value in AF management.
Interestingly, recent studies have demonstrated the implication
of oxidative stress within the atrial tissue during AF suggesting
a potential role in the remodeling phenomenon (Van Wagoner,
2003; Korantzopoulos et al., 2007).
Further evidence of the role of ROS and RNS in the develop-
ment of AF has been provided. Thus, AF induced by rapid atrial
pacing in pigs is characterized by increased nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase activity and superox-
ide production in the left atrium (Dudley et al., 2005). Right
human atrial appendages of patients with AF exhibit higher lev-
els of the nitrosative and oxidative stress markers 3-nitrotyrosine
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and protein carbonyls, respectively, compared with patients with
sinus rhythm (Mihm et al., 2001). In mice, chronic cardiac over-
expression of Rac1 represents a novel model for AF. Rac1 GTPase
contributes to the pathogenesis of AF and might represent a target
for the prevention and its treatment (Adam et al., 2007).
Myocardial ischemia–reperfusion
Themyocardiumcan tolerate brief periods (up to 15min)of severe
and even total myocardial ischemia without resultant cardiomy-
ocyte death. This is observed in clinical settings like coronary
vasospasm, angina, and balloon angioplasty, and is therefore not
associated with concomitant myocyte death (Kloner and Jen-
nings, 2001a,b). It was suggested that endothelial dysfunction
occurs early during reperfusion of a previously ischemic tissue
and that it will be present for long time (Lefer and Lefer, 1996).
The hypoxia and reoxygenation signiﬁcantly increased pulmonary
veins arrhythmogenesis and induces different electrophysiological
responses in the right and left atria, which may play a role in the
pathophysiology of AF (Lin et al., 2012). In a clinical setting, reper-
fusion injury after revascularization of the ischemia-related artery
is manifested by myocardial stunning, reperfusion arrhythmia,
myocyte death, and endothelial- and microvascular-dysfunction
including the no-reﬂow phenomenon (Moens et al., 2005). Early
reperfusion is an absolute prerequisite for the survival of ischemic
myocardium.However, this process has been referred as the double
edged sword because reperfusion may itself lead to accelerated and
additional myocardial injury beyond that generated by ischemia
alone (Braunwald and Kloner, 1985). This paradoxical effect
results in a spectrum of reperfusion-associated pathologies, col-
lectively called reperfusion injury (Yellon and Hausenloy, 2007).
These observations are consistent with the notion that reintroduc-
tion of abundant oxygen at the onset of reperfusion evokes a burst
of ROS within the ﬁrst few minutes of reﬂow as demonstrated
experimentally and in patients with acute myocardial infarction
undergoing thrombolysis (Béard et al., 1994) or percutaneous
coronary intervention (Babu et al., 2011), and patients undergoing
open heart on-pump surgery (Akila et al., 2007).
Role of oxidative stress in atrial ﬁbrillation
The ability of tissues to tolerate ROS is partly conditioned by
the activity of their antioxidant defense system to scavenge and
degrade ROS to non-toxic molecules. Antioxidant enzymes are
mainly located in the intracellular space, and, the antioxidant mol-
ecules both within the intra- and extra-cellular spaces. The setting
of an ischemia–reperfusion event alters this homeostasis giving
rise to a prevalence of prooxidants over antioxidant activity (oxida-
tive stress). Consequently, the increased ROS concentration at the
steady-state causes direct damage to lipids, proteins, and DNA.
A large body of experimental evidence supports the notion that
ROS-generated reperfusion injury occurs when oxygen is reintro-
duced to the ischemic tissue (Hess and Manson, 1984; Weisfeldt
et al., 1988; Opie, 1991; Kilgore and Lucchesi, 1993; Zughaib et al.,
1994; Ambrosio and Tritto, 1999; Park and Lucchesi, 1999). Previ-
ously, it has been proposed the beneﬁcial effects of ROS occur at
moderate concentrations and involve physiological roles in cellu-
lar responses (Martindale and Holbrook, 2002; Valko et al., 2007).
It is of interest to mention that superoxide is able to react with
nitric oxide (NO) via a high rate constant non-enzymatic reaction
to form peroxynitrite, a highly peroxidant molecule responsible
for additional structural changes, such as nitrotyrosine derivatives
formation, nitrosylation, and oxidation of thiol groups. Redox
signaling processes are involved in the activation of many signal
transduction protein kinases and transcription factors, the stimu-
lation of DNA synthesis and expression of growth-related genes,
and the regulation of myocardial excitation–contraction coupling.
Interestingly, while high levels of peroxynitrite may induce non-
speciﬁc toxic effects, at lower levels it is capable of modulating
signaling events in vivo indicating an additional level of complex-
ity. NO synthase normally generate NO but may instead generate
superoxide if it becomes “uncoupled,” a state that may occur from
deﬁciency of NOS cofactor tetrahydrobiopterin (BH4) or the NOS
substrate l-arginine (Verhaar et al., 2004). Interestingly, ROS pro-
duced by NADPH oxidases can promote ROS generation by other
sources thereby amplifying total levels of ROS. Superoxide may
oxidize and degrade BH4, thereby leading to eNOS uncoupling.
Similarly, NADPH oxidase-derived ROS may also activate xan-
thine oxidase (Li and Shah, 2004). The evidence indicates that
the primary source of superoxide production in the human atrial
myocardium is an NADPH oxidase, whose activity is increased in
AFpatients comparedwithmatchedpatients in sinus rhythm(Kim
et al., 2005), what is accompanied by increased mRNA expression
of NOX2 and P22 phox. In addition, it was reported that AF is
associated with a 6.9-fold increase in active Rac1 (Adam et al.,
2007). Possible mechanisms of Rac1 activation include increased
Ang II receptor activation, or increased cytosolic Ca2+ (Wassmann
et al., 2001; Cook-Mills et al., 2004; Li et al., 2006).
Atrial remodeling and ROS
Compelling evidence shows that AF development and perpetua-
tion depends on the electrophysiological and structural substrates
of the atria (Allessie et al., 2002; Nattel et al., 2007). The struc-
tural substrates refer to abnormalities in atrial architecture such
as atrial dilatation (Kojodjojo et al., 2007), ﬁbrosis (Everett and
Olgin, 2007), apoptosis phenomena, tissue dedifferentiation, etc.
(Shiroshita-Takeshita et al., 2005). The cardiomyocytes have to
cope with new circumstances and consequently change the expres-
sion and organization pattern of proteins involved in activation,
conduction, and contraction. Ions like Ca2+, Na+, and K+ are
important players in the excitation–contraction cycle, and the
expression patterns of their channels and other proteins involved
in ion homeostasis have been extensively studied. Oxidative mem-
brane damage has been found to be of great pathological impor-
tance in ischemia–reperfusion of myocardial tissue injury. At the
molecular level, membrane functions may be modiﬁed by direct
attack of ROS on its related components. ROS exposure inﬂuences
the physical properties of membranes, and hence ion transport
mainly due to changes in the dielectric constant,which is enhanced
by lipid peroxidation (Killig and Stark, 2002). This effect is caused
by the accumulation of polar products of lipid peroxidation,
or secondary reactive species, in the membrane interior. Conse-
quently, membrane barrier, experienced by the charged species
throughout their translocation across the membrane, would be
further reduced (Stark, 2005) giving rise to many of the activation
phenomenaof membrane transport described in the literature. Ion
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channels (contrary to ion carriers) provide polar pathways for ions
across the hydrophobic membrane barrier. For their proper func-
tioning, the structural element forming the polar pathway must be
inserted into the membrane, a process which is substantially facil-
itated by increased dielectric constant. Membrane proteins have a
natural lipid environment and are therefore particularly exposed
to an eventual attack of secondary reactive species.
The oxidative modiﬁcation of (Na+K)-ATPase has been stud-
ied considering the direct and the indirect inactivation pathways
(Shao et al., 1995). In agreement with this view it was reported
that erythrocyte (Na+K)-ATPase activity correlated negatively
with 8-isoprostane (in vivo index of lipid peroxidation) in hyper-
tensive and normotensive subjects (Rodrigo et al., 2007a). Several
authors have found altered mRNA and/or protein levels of ion
channels during AF (Van Wagoner et al., 1997; Van Gelder et al.,
1999; Brundel et al., 2001). In this setting, downregulation has
been described for the L-type calcium channel (Lai et al., 1999),
the sarcoplasmic reticulum calcium ATPase (Brundel et al., 1999),
and several potassium channel subunits (Brundel et al., 1999; Lai
et al., 1999), whereas the expression of other proteins involved
in calcium handling like the sodium/calcium exchanger, phospho-
lamban, calsequestrin, and the ryanodine receptorwere not altered
(Lai et al., 1999; Van Gelder et al., 1999; Brundel et al., 2001). It is
of interest to mention that electrical remodeling is capable to alter
ion channels being the base of AF, such as L-type calcium channel
(Cav1.2), inward rectiﬁer potassium channel (Kir2.1), transient
outward potassium channel (Kv4.3), ultrarapid delayed recti-
ﬁer potassium channel (Kv1.5), acetylcholine-activated potassium
channel (Kir3.1), ATP-sensitive potassium channel (Kir6.2), fast
sodium channel (Nav1.5). For example, it has been shown that in
AF patients with a reduced density of outward potassium current,
the expression of the potassium channel Kv1.5 subunit decreases
(Van Wagoner et al., 1997). This indicates that the current den-
sities are inﬂuenced by alterations in channel protein expression
level, an observation that was also described in a dog model of
chronic AF (Gaspo et al., 1997; Yue et al., 1997, 1999). ROS pro-
duction occurs in the heart sarcolemmal and t-tubule membranes
where NOX2 is located and sensitizes nearby ryanodine recep-
tors in the sarcoplasmic reticulum. This triggers a burst of Ca2+
sparks and, consequently, arrhythmogenic Ca2+ waves (Prosser
et al., 2011). These effects were prevented by the antioxidant N -
(2-mercaptopropionyl) glycine in isolated cardiomyocytes, after
pretreatment with digitoxin, known to increases the incidence
of arrhythmogenic spontaneous Ca2+ waves, decreases the sar-
coplasmic reticulum Ca2+ load, and increases both ROS and
ryanodine thiol oxidation (Ho et al., 2011). In addition, inhibitors
of NADPH oxidase, mitochondrial ATP-dependent channels, or
permeability transition pore, but not inhibitors of xanthine oxi-
dase, also were able to inhibit these effects. Furthermore, it was
demonstrated that H2O2 enhances the late, slowly inactivating
current through cardiac Na channels, thereby leading to action
potential prolongation and arrhythmias (Song et al., 2006), being
Ca2+/calmodulin-dependent protein kinase II (CaMKII)δ sug-
gested as an important factor for ROS-induced arrhythmias.
This is supported by the ﬁnding that the expression and activ-
ity of CaMKII are increased in arrhythmias (Wagner et al., 2006),
although ROS-induced sarcoplasmic reticulum Ca2+ release may
be a prerequisite for ROS-dependent CaMKII activation. It is
of interest to mention that it was identiﬁed a ROS-dependent,
Ca2+ independent CaMKII activation by oxidative modiﬁcation
of methionine 281/282, thereby showing that direct activation of
CaMKII by ROS engenders Ca2+ autonomous activity, a clear but
previously molecular mechanism by which CaMKII can integrate
Ca2+ and ROS signals (Erickson et al., 2008).
There is considerable evidence supporting that the function
of the L-type Ca2+-channel is inﬂuenced by the redox state
of the cell, leading to intracellular Ca2+ overload. Ischemia–
reperfusion causes an increased in the production of 20-
hydroxyeicosatetraenoic acid (20-HETE), a potent vasoconstrictor
that activates L-type Ca2+ channels. Inhibition of 20-HETE pro-
duction has been shown to reduce infarct size caused by ischemia.
In isolated crat cardiomyocytes, it was shown that this effect
includes 20-HETE stimulation of NADPH oxidase-derived super-
oxide production, which activates L-type Ca2+ channels via a
PKC-dependentmechanism (Zeng et al., 2010). The effect explain-
ing the action of ROS on the heart was provided by the ﬁrst
time relating the concomitant disruption of calcium and energy
metabolism. It was concluded that ROS-induced glycolytic inhi-
bition and Ca2+ overload (Corretti et al., 1991). More recently,
it was reported that a related mechanism for the development of
atrial dysrhythmias is Ca2+ alternans, a subcellular phenomenon
caused by modulation of sarcoplasmic reticulum Ca2+ release,
which is mediated, at least in part, by local inhibition of energy
metabolism (Kockskämper and Blatter, 2002). Furthermore, atrial
myocytes glycolysis regulates Ca2+ release from the sarcoplasmic
reticulum by direct modulation of ryanodine receptors activity by
intermediates and products of glycolysis and modulation of sar-
coplasmic reticulum Ca2+-ATPase activity through local changes
of glycolytically derived ATP (Kockskämper et al., 2005). In sup-
port of these postulated mechanisms, it has been demonstrated
that glycolytic inhibition interacts with the aged and ﬁbrotic atria
to amplify intracellular Ca2+handling abnormalities that facilitate
AF development (Ono et al., 2007). Furthermore, in aged ﬁbrotic
unlike in adult rat hearts, glycolytic inhibition promotes ventricu-
lar ﬁbrillation by activation of ATP-sensitive K channels, CaMKII,
and Na+–Ca2+-exchanger (Morita et al., 2011), but these arrhyth-
mias were suppressed by the reducing agent N -acetylcysteine and
CaMKII inhibitor KN-93 (Morita et al., 2009).
Gap junction proteins
Gap junctions are involved in cell–cell coupling; they form electri-
cal conduits between adjacent myocardial cells, permitting rapid
spatial passage of the excitation current essential to each heartbeat.
Arrhythmogenic decreases in gap junction coupling are a charac-
teristic of stressed, failing, and aging myocardium, but the mech-
anisms of decreased coupling are poorly understood. Intercellular
gap junction channels are formed by homomeric or heteromeric
connexin subunits (Köhler and Hoyer, 2007), thus supporting the
concept that local intercellular electrical communication between
the cardiomyocytes occurs through these structures (Félétou and
Vanhoutte, 2006). This provides an electrical continuity allowing
a uniform membrane potential among coupled cells. Neverthe-
less, connexins functions are beyond facilitating the exchange of
metabolites and electrical signals between cells and contributing
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to cardiomyocyte volume regulation (Burra and Jiang, 2011). The
role of gap junction channels on cardiac impulse propagation is
complex. Atrial muscle preferentially expresses connexins 40 and
43. Microtubules have a well-studied role in the trafﬁcking of con-
nexin 43 to the plasma membrane. EB1 is a protein involved in
the targeted delivery of connexin 43 to adherens junctions (Shaw
et al., 2007). Oxidative stress perturbs connexon forward trafﬁck-
ing along microtubules to gap junctions (Smyth et al., 2010) and
EB1 levels are reduced at intercalated disks in end-stage human
ischemic cardiomyopathy and in adult mouse hearts exposed to
acute ischemia–reperfusion injury or acute oxidative stress alone.
Furthermore, mutational disruption of the EB1–tubulin interac-
tion mimicked the effects of oxidant stress, including a reduction
in surface Cx43 expression (Tomaselli, 2010). In contrast, dietary
selenium, an antioxidant compound, exerts a cardioprotective
effect that might be mediated by a reduced oxidative stress, a
lower connexin 43 dephosphorylation, and a decreased TNF-α
expression (Tanguy et al., 2011). Furthermore, in endothelial cells
challenged by hypoxia-reoxygenation it was recently found that
p47phox rather than NADPH oxidase-derived ROS affects the
modulation of intercellular coupling, suggesting a contribution of
a cross-talk between connexin 40 and NADPH oxidase (Yu et al.,
2010).
The modulation by gap junction channels is prominent in car-
diac tissues such as sinoatrial node-atrial muscles, atrioventricular
node-His bundle,His bundle–bundle branch, and Purkinje ﬁbers-
ventricular muscles (Desplantez et al., 2007). Under conditions
of oxidative stress connexin 43 distribution pattern is heteroge-
neous giving rise to aberrant electrical conduction, facilitating
self-perpetuation of re-entry pathways thereby causing the devel-
opment of AF (Tansey et al., 2006; Wilhelm et al., 2006). However,
further studies are still lacking to determine the precise molecu-
lar basis linking oxidative stress with these complex phenomena
occurring in postoperative AF.
IMPLICATIONS OF INFLAMMATION FOR POSTOPERATIVE
ATRIAL FIBRILLATION
CLINICAL AND EXPERIMENTAL EVIDENCE
Inﬂammation is another heavily studied pathophysiological
process implicated in the pathophysiology of postoperative AF
(Aviles et al., 2003; Korantzopoulos et al., 2003; Boos et al.,
2006).Aside from increasedROS and calciumoverload, inﬂamma-
tory cell inﬁltration into the myocardium may promote oxidative
injury, directly affecting atrial myocyte contraction (Mihm et al.,
2001), and electrical conduction (Kumagai et al., 1997). Accord-
ingly, patients with persistent AF have increased white cell count
(Abdelhadi et al., 2004), as well as plasma levels of the biomarker
C-reactive protein (CRP), relative to patients with paroxysmal AF,
and both of these patient groups have levels greater than those
with no AF (Chung et al., 2001). Thus, cardiac surgery with extra-
corporeal circulation leads to elevation of CRP, interleukin-6, and
the complement system (Gaudino et al., 2003; Canbaz et al., 2008;
Echahidi et al., 2008). The temporal course of AF occurring after
cardiac surgery closely follows the activation of the complement
system and release of proinﬂammatory cytokines. It was demon-
strated that the levels of CRP on postoperative day 2 were more
elevated in patients that experienced postoperative AF than in
those that did not (Bruins et al., 1997). It was reported that a more
pronounced increase in postoperative white cell count indepen-
dently predicts development of postoperative AF (Lamm et al.,
2006). During the ﬁrst hour of reperfusion, superoxide triggers
neutrophil inﬁltration, which increases cardiac damage by further
release of ROS, inﬂammatory mediators, and proteases (Yellon
and Hausenloy, 2007). Chemokines are known to induce leuko-
cytemigration, growth, and activation. Speciﬁcally, the chemokine
interleukin-8 appears tohave a fundamental role in regulatingneu-
trophil localization in ischemic myocardium. In mice, CXCL2, the
homolog of human interleukin-8, is up-regulated in reperfused
myocardium (Vandervelde et al., 2007). The chemokine response
in ischemic tissues may be induced by various factors, including
ROS, cytokines (e.g., TNF-α and complement), and NF-κB acti-
vation (Chandrasekar et al., 2001). Prospective epidemiological
studies have shown that serum levels of CRP is a strong pre-
dictor of cardiovascular ischemia–reperfusion injury events, such
as myocardial infarction, postoperative AF, and stroke (Kinoshita
et al., 2011). Several studies revealed an independent association
of high plasma CRP levels with adverse prognosis in acute myocar-
dial infarction patients. Interestingly, preconditioning was found
to inhibit post-ischemic CRP increases in a rat model of acute
myocardial infarction (Valtchanova-Matchouganska et al., 2004).
Recently, it has been discussed the possible role of microR-
NAs in AF initiation and maintenance, as they inﬂuence cardiac
excitability and other processes pertinent to AF (Wang et al.,
2011b). Enhanced expression of miR-200, a family of microRNAs
affecting tumorigenesis and chemosensitivity, can modulate the
oxidative stress response. It was reported that miR-200a also sen-
sitizes tumors to treatment, which could account for the limited
success of antioxidants in clinical trials (Mateescu et al., 2011).
As a consequence of inﬂammation, impairment on the elec-
trical properties of atrial tissue, such as inhomogeneity in atrial
conduction may result (Ishii et al., 2005; Tselentakis et al., 2006).
INTERRELATIONSHIP BETWEEN OXIDATIVE STRESS AND
INFLAMMATION
Indeed the role of inﬂammation response in the intra- and extra-
cellular mechanisms implicated in this disorder cannot be sepa-
rated from that of oxidative stress. The biochemical nexus between
these two processes represents an essential piece in the puzzle.
It is of interest to mention that the transcriptional factor NF-
κB was found to play a pivotal role in this connection (Pavlovic
et al., 2002). It has been found that this transcriptional factor
responds to changes of the cellular oxidative status (Chandra
et al., 2000). When NF-κB is activated, by phosphorylation of its
inhibitory cofactor, it bonds to a DNA response element (ARE)
and promotes the transcription of genes coding to inﬂammation
mediators such as CRP, interleukin-6, and ﬁbrinogen, among oth-
ers (Liakopoulos et al., 2007).NF-κBactivationhas been associated
with cardiac dysfunction, ventricular hypertrophy, and maladap-
tive cardiac growth (Opie et al., 2006). Increased levels of several
inﬂammation markers were found in serum and atria biopsies of
AF and postoperative AF patients (Korantzopoulos et al., 2003;
Neuman et al., 2007; Yu et al., 2010). Therefore it is reasonable to
assume that oxidative stress and inﬂammation response act in a
synergic way in the underlying pathophysiological mechanisms of
Frontiers in Physiology | Cardiac Electrophysiology April 2012 | Volume 3 | Article 93 | 6
Rodrigo Prevention of postoperative atrial ﬁbrillation
postoperative AF, giving the foundation for studies involving anti-
inﬂammatory AF therapy (Halonen et al., 2007; Goldstein et al.,
2008).
CELL DEATH IN ISCHEMIA–REPERFUSION: NECROSIS,
APOPTOSIS, AND AUTOPHAGY
Necrosis is a catastrophic type of cell death that is uncontrol-
lable and does not involve any speciﬁc mechanisms. Necrosis
is classically characterized by early plasma membrane rupture
and swelling of cytoplasmic organelles, in particular mitochon-
dria. It only refers to an irreversible stage of cell death, even
though dying cells generally progress from a reversible to an irre-
versible stage. ROS is involved in necrotic cardiomyocyte death
through MPT pore opening. Apoptosis has been implicated in
the pathogenesis of several acute and chronic conditions affect-
ing the cardiovascular system in the last decade (Gale et al.,
2011). The loss of endothelial cells precedes and may predis-
pose cardiomyocytes to undergo apoptosis (Dallabrida et al.,
2005), indicating that salvaging endothelial cells is of paramount
importance. It is likely that myocyte apoptosis is initiated dur-
ing ischemia but dependent on reperfusion injury. Reperfusion
appears to accelerate apoptosis when compared with permanent
occlusion (Whelan et al., 2010). Active caspases cleave vital sub-
strates in the cell, such as actin, actinin, β-myosin heavy chain,
myosin light chain, tropomyosin, and cardiac troponins, leading
to cellular demise (Communal et al., 2002). The “intrinsic” path-
way utilizes mitochondria to induce cell death by opening the
mitochondrial permeability transition pore (MPTP) or ruptur-
ing the outer mitochondrial membrane, both of which trigger the
sudden and complete release of cytochrome c and other proteins
from the intermembrane mitochondrial space into other cellular
compartments. The “intrinsic” pathway is primarily activated in
cardiac myocytes by cellular stimuli, such as hypoxia, ischemia–
reperfusion, and oxidative stress, which perturb the MPTP and
increase the permeability of the outer and inner mitochondr-
ial membranes (Singh et al., 2011). Once released, cytochrome
c binds to the cytosolic protein apaf1 and facilitates formation
of the “apoptosome” complex, which results in caspase-9 acti-
vation that provokes caspase-3 activation (Adrain and Martin,
2001). Smac/DIABLO indirectly activates caspases by sequester-
ing caspase-inhibitory proteins, while the mitochondrial release
of endonuclease-G and apoptosis-inducing factor results in their
translocation into the nucleus where they directly or indirectly
facilitate DNA fragmentation (Cande et al., 2002). Experimental
studies in mice demonstrated that the activation of Fas can induce
apoptosis in cardiac myocytes and that Fas is a critical mediator
of myocardial infarction due to ischemia–reperfusion in vivo (Lee
et al., 2003).
Autophagy – in contrast to necrosis and apoptosis, autophagy
is primarily a survival mechanism. Cellular oxidative stress and
ROS have been reported to serve as important autophagic stim-
uli during periods of ischemia–reperfusion (Hariharan et al.,
2011). Autophagic degradation and removal of damaged oxi-
dized proteins in response to low to moderate oxidative stress is
reportedly beneﬁcial for cells. Conversely, severe oxidative stress
and increasing amounts of ROS may activate signaling path-
ways that lead to autophagy-induced cell death. In addition,
ultrastructural atrial remodeling characterized by an impaired
cardiac autophagy was found in patients developing postopera-
tive AF after coronary artery bypass surgery (García et al., 2011).
Whether autophagy promotes cell survival or death depends upon
the severity and degree of stress in the cellular environment (Essick
and Sam, 2010). During the initial period of ischemia, enzyme
XO is formed, and substrates for XO (hypoxanthine and xan-
thine) accumulate. Upon reperfusion, the reintroduction of O2
leads to XO-mediated superoxide generation due to the presence
of xanthine and hypoxanthine (Ushio-Fukai, 2009). During this
period, ATP generation decreases and results in the phosphory-
lation of 5′ adenosine monophosphate-activated protein kinase
(AMPK), which leads to autophagosome formation through inhi-
bition of mammalian target of rapamycin (mTOR; Matsui et al.,
2008). Meanwhile, ROS damage organelles and cytosolic proteins
and cause mitochondrial lipid peroxidation, all of which exacer-
bate autophagy (Juhaszova et al., 2004). Additionally, antioxidant
enzymes, such as CAT and SOD, are targeted by autophago-
somes. This ultimately leads to the induction of cell death and
is thus detrimental to tissue function. Furthermore, AMPK activ-
ity decreases during reperfusion, thus increasing autophagic death
and up-regulating beclin-1 (Zhu et al., 2007). Autophagy has been
reported to be involved in cardioprotection against lethal ischemic
injury; thus, repetitive ischemia by coronary stenosis or occlu-
sion enhances autophagy and subsequent cardioprotection when
compared with classical ischemia–reperfusion insult (Yan et al.,
2009). Aside from the key role that the chemokine MCP-1 plays in
cardiac damage following ischemia, it also mediates autophagy
through MCP-1-induced protein (MCPIP), a novel zinc-ﬁnger
protein that has transcription factor-like activity (Zhou et al.,
2006). MCPI stimulates inducible NO synthase, translocation of
the NADPH oxidase subunit phox47 from the cytoplasm to the
membrane, ROS production, induction of endoplasmic reticu-
lum stress markers HSP40 and autophagy, as indicated by beclin-1
induction,cleavage of microtubule-associatedprotein 1 light chain
3 and autophagolysosome formation, and apoptosis, respectively
(Younce and Kolattukudy, 2010).
A wide survey of AF is beyond the scope of the present chapter.
Nevertheless, a mechanistic hypothesis representing the effects of
ischemia, as well as those derived from the re-establishment of
blood ﬂow in the ischemic myocardium, together with the inﬂam-
mation caused by the surgical procedure and enhanced by ROS is
presented in Figure 1.
PREVENTION OF POSTOPERATIVE ATRIAL FIBRILLATION
CURRENTLY AVAILABLE PHARMACOLOGIC PROPHYLAXIS
The high incidence of postoperativeAF has led to the development
of therapies that target the sympathetic nervous system, refrac-
tory period, or alter cardiac conduction. In summary, available
evidence strongly supports the use of β-blockers as standard pro-
phylaxis of postoperative AF (Koniari et al., 2010). However, while
these agents reduce the incidence of the arrhythmia, they do not
eliminate it. Moreover,β-blockers should not be used in intolerant
patients or as additive therapy in high risk patients. To study the
evidence supporting the use of traditional pharmacologic thera-
pies, other than β-blockers, for the prevention of postoperative AF,
the reader could be directed to a recent review (Davis et al., 2010).
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FIGURE 1 | Schema representing the hypothesis for the role of oxidative
stress and inflammation in the pathophysiology of postoperative atrial
fibrillation in patients subjected to cardiac surgery with extracorporeal
circulation. NF-κB, nuclear factor kappaB; TNF-α, tumor necrosis factor-α; IL-6,
interleukin-6; TGF-β, transforming growth factor-β; RP, refractory period.
Adapted from Rodrigo et al. (2008) with permission.
NOVEL THERAPEUTIC AGENTS
Atpresent,preventive strategies against postoperativeAFoffer only
suboptimal beneﬁts. Despite improvements in anesthesia, surgical
technique, and medical therapy, the incidence of this complication
of surgery remains high. Likely, this could be the result of a limited
knowledge of the mechanisms for the development of postopera-
tive AF. Therefore, there is a need of alternative therapies. Accord-
ingly, newly identiﬁed pathways have given rise to novel strate-
gies under investigation, including renin–angiotensin–aldosterone
modulators, statins, non-steroidal anti-inﬂammatory drugs, cor-
ticosteroids, thiazolidinediones, n−3 polyunsaturated fatty acids
(n−3 PUFA), ascorbic acid, N -acetylcysteine, and sodium nitro-
prusside. Our interest will be focused in the reinforcement of the
antioxidant defense system, since ROS could contribute to the
mechanism accounting for structural remodeling and inﬂamma-
tion of myocardial tissue through the occurrence of ischemia–
reperfusion events. Therefore, it should be expected a decreased
risk of myocardial tissue for the development postoperative AF in
the presence of increased antioxidant activity.
Antioxidants
The available evidence for oxidative stress in the pathophysiol-
ogy of postoperative AF has stimulated the prophylactic use of
antioxidants. Based on the pathogenic role of ROS and RNS, it
should be expected that treatments with exogenous antioxidant
agents protect against reperfusion injury. Clinical trials designed
to study cardioprotection by long-termadministration of vitamins
CandEhave failed todemonstrate beneﬁcial effects (Flaherty et al.,
1994; Stephens et al., 1996; Rapola et al., 1997; GISSI-Prevenzione
Trial, 1999; Heart Protection Study Collaborative Group, 2000;
Yusuf et al., 2000; de Gaetano, 2001; Guan et al., 2003; Tsujita
et al., 2006; Cook et al., 2007; Sesso et al., 2008). This disappointed
result could be due to the lack of consideration of the pharmaco-
dynamics and/or the biochemical properties of these compounds.
Thus, the efﬁcacy of vitaminC asROS scavenger cannot be reached
by oral doses. In turn, high doses of vitamin E (more than 400 IU)
could exert a prooxidant effect and should be avoided. Some
studies have suggested that antioxidant agents attenuate left ven-
tricular remodeling following acute myocardial infarction. When
these patients had undergone primary percutaneous translumi-
nal coronary angioplasty, pretreatment with allopurinol, an XO
inhibitor, resulted in effective inhibition of oxygen-derived rad-
ical generation during reperfusion therapy and left ventricular
function recovery (Guan et al., 2003). Accordingly, in a model
of AF induced by rapid atrial pacing in pigs, it was demonstrated
that increased activity of NADPH and xanthine oxidases in atrial
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tissue could account for increased superoxide anion, what was
prevented by the inhibitors apocinin and oxypurinol, respectively
(Dudley et al., 2005). More recently, administering the free radical
scavenger edaravone to patients with acute myocardial infarction
immediately prior to reperfusion signiﬁcantly reduced infarct size
and reperfusion arrhythmia (Tsujita et al., 2006). A prospective,
randomized, placebo-controlled pilot study reported a signiﬁ-
cant reduction of the incidence of postoperative AF in patients
undergoing coronary artery bypass and/or valve surgery who were
treated with N -acetylcysteine (Ozaydin et al., 2011). However,
other attempts, such as intravenous bolus of SOD (Yusuf et al.,
2000), showed no beneﬁcial effect on patient outcome.
Concerning the role of antioxidant vitamins in the prevention
of postoperative AF, although the scientiﬁc rationale, epidemio-
logic data, and retrospective studies have been persuasive, prospec-
tive, randomized, placebo-controlled trials have not veriﬁed the
actual beneﬁt of antioxidant vitamins in human diseases (Rodrigo
et al., 2007b). There are several possible contributory factors that
could explain this discrepancy, and the lack of consideration of
basic aspects, such as the pharmacokinetic properties and bio-
chemical effects of antioxidant vitamins at the cell level. Consistent
with this view, previous attempts to reduce free radical produc-
tion with oral vitamin C following primary coronary angioplasty
for AMI failed to attenuate increased F2-isoprostane production
(Guan et al., 1999). Jaxa-Chamiec et al. (2005) performed a ran-
domized, double-blind, placebo-controlled multicentre study in
800 patients and analyzed the combined effects of vitamins C and
E through infusion and capsules but could not demonstrate a
major effect of this antioxidant treatment on the clinical outcome,
although diabetic patients showed a reduction in 30-day cardiac
mortality (Jaxa-Chamiec et al., 2009). It should be noted that the
authors acknowledged that the dose of vitamin C used only raised
plasma levels to 0.1mmol/L, a concentration 100 times lower than
that required for scavenging superoxide anion. Recently, a meta-
analysis of randomized controlled trials concluded that antiox-
idant vitamins C and E may have prophylactic effect to reduce
the incidence of postoperative AF and all-cause arrhythmia fol-
lowing cardiac surgery; however, the overall quality of current
studies is poor and further research is needed (Harling et al., 2011;
Rasoli et al., 2011). Most investigations on the protective effects
of vitamins C and E have merely focused on their antioxidant
power.However, these compoundshave thepotential to inﬂuence a
broad range of mechanisms underlying human health and disease;
the biological properties of α-tocopherol and ascorbic acid over-
whelm their antioxidant effects. Despite the enormous interest in
antioxidant vitamins as potential protective agents against human
disease development, the actual contributions, and mechanisms
of such compounds remain unclear. The biological properties and
beneﬁcial effects of vitamins C and E against postoperative AF
have been reviewed (Rodrigo et al., 2010) and will be analyzed
separately.
Vitamin E
This antioxidant, primarily α-tocopherol, is the major peroxyl
radical scavenger in biological lipid phases, such as membranes
or LDL (Upston et al., 2001; Terentis et al., 2002). The antiox-
idant action of vitamin E has been ascribed to its ability to act
chemically as a lipid-based free radical chain-breaking molecule,
thereby inhibiting lipid peroxidation through its own conversion
into an oxidized product, α-tocopheroxyl radical. α-Tocopherol
can be restored by reducing α-tocopheroxyl radicals with redox-
active reagents, such as vitamin C or ubiquinol (Shi et al., 1999).
The discovery of α-tocopheryl phosphate, a novel and natural
water-soluble form of vitamin E, should expand the knowledge
of the roles of this vitamin in biological systems (Gianello et al.,
2005) and facilitate its intravenous administration. In fact, vitamin
E oral supplementation hours before acute episodes of oxidative
stress may be not effective, but short-term parenteral administra-
tion was shown to enrich vitamin E in endothelial cells (Engelhart
et al., 1998). In clinical studies of ischemia–reperfusion injury,
positive effects of a multivitamin antioxidant solution, includ-
ing preoperative administration of vitamin E, were described for
revascularization of the lower extremities (Rabl et al., 1995), kid-
ney transplantation (Rabl et al., 1993), liver surgery, and aortic
aneurysm repair (Bartels et al., 2004). However, homologous stud-
ies in the myocardium have not been performed. Although it was
reported that long-term vitamin E supplements given at high
dosage (≥400 IU/day) may increase all-cause mortality (Miller
et al., 2005), this was not the case for short-term administration
of conventional doses required for the prevention of myocardial
reperfusion damage.
Vitamin C
Intraarterial administration of high doses of ascorbate has demon-
strated to abolish the in vivo effects of superoxide anion in the
impairment of vascular endothelial function in subjects with
essential hypertension (Schneider et al., 2005). In addition, recent
in vitro studies have also been successful to study the effects in vitro
of oxidative stress with and without this vitamin C concentration,
thus validating ascorbate to counteract the effects of oxidative
stress (Virdis et al., 2009). It should be noted that most human
cells have vitamin C transporters, coupled with sodium transport
at a ratio Na:ascorbate= 2:1, having a K0.5 by 70μmol/L, being
distributed about 90% in the cytosol (Mackenzie et al., 2008).
When vitamin C is given by mouth, the relationship between oral
dose and plasma concentration is sigmoidal. Its concentration in
plasma is tightly controlled and excess of vitamin C is excreted as
a function of dose, being completely saturated at doses of 400mg
daily and higher, producing a steady-state plasma concentration of
approximately 80μmol/L (Graumlich et al., 1997). Unfortunately,
while this concentration approaches to that required for enzyme
modulation, it is not enough to scavenge superoxide anion. There-
fore, in settings accompanied by oxidative stress, such as the acute
myocardial infarction, or percutaneous coronary intervention fol-
lowing acute myocardial infarction, it should not be expected a
beneﬁcial effect of oral administration of vitamin C in the pre-
vention of oxidative damage, and intravenous infusion could be
consideredwith this purpose. Indeed, superoxide reactswithNOat
a rate 105-fold greater than the rate at which superoxide reacts with
ascorbic acid (Jackson et al., 1998). As a consequence, 10mmol/L
ascorbate is needed to support its competition with NO for super-
oxide. It should be expected a high rate of cellular transport at
10mmol/L ascorbate plasma concentration, being saturated the
transporters, as this concentration is much higher than V max.
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Short-term infusion of high vitamin C doses make possible to
reach peak concentrations higher than 20mmol/L, but being over
10mm/L for 3 h (Duconge et al., 2008). Interestingly, plasma levels
of such magnitude, or three times higher, have not demonstrated
adverse events, except in the case of known complications such
as renal failure or glucose 6 phosphate dehydrogenase deﬁciency
(Padayatty et al., 2010). Therefore, these data are consistent with
the fact that vitamin C high doses offer an unexplored therapeu-
tic opportunity to counteract the myocardial reperfusion damage
caused by percutaneous coronary intervention. Despite oral doses
of vitamin C fail to protect the heart against the effect of perox-
ynitrite, some beneﬁcial effects other than that of superoxide scav-
enging may be observed when ascorbate is administered following
acute myocardial infarction. Accordingly, in patients undergoing
elective percutaneous coronary intervention, impaired microcir-
culatory reperfusion is improved by vitamin C infusion (Basili
et al., 2010). Furthermore, in patients subjected to thrombolysis,
SOD in the blood was found signiﬁcantly reduced; whereas the
activity of the oxidant enzyme XO, and malondialdehyde levels
were found signiﬁcantly increased. However, oral supplementa-
tion of vitamin C to the post reperfusion patients restored these
parameters back to normal or near normal levels (Bhakuni et al.,
2006). These effects could be related to the modulation of ROS
production by vitamin C. A major enzymatic source of ROS is
given by their production via NADPH oxidase, an enzyme sub-
jected to downregulation by vitamin C. In addition, vitamin C
prevents the oxidation of tetrahydrobiopterin, a cofactor of eNOS
that is highly sensitive to oxidation. When tetrahydrobiopterin
is oxidized, eNOS activity becomes uncoupled, resulting in the
production of superoxide rather than NO, thus enhancing the
consequences of oxidative damage (Yang and Ming, 2006). There-
fore, it should be expected a beneﬁcial effect of vitamin C in the
outcome of patients, even at oral doses, when it is administered
before cardiac surgery with extracorporeal circulation. On this
line, another clinical model of oxidative stress likely to have bene-
ﬁcial effects of oral doses of vitamin C is postoperative AF. This is
supported by previous studies demonstrating a major reduction
in the incidence of postoperative AF in patients subjected to coro-
nary artery bypass who were given 2 g of vitamin C the day before
the surgery, followed by 500mg daily until the ﬁfth postopera-
tive day (Carnes et al., 2001). In agreement with these data, more
recent studies demonstrated that the combination of ascorbic acid
and β-blockers may be more effective in reducing postoperative
AF than β-blockers alone (Eslami et al., 2007), and that supple-
mentation of vitamin C reduces the incidence of postoperative AF,
the time needed for rhythm restoration and length of hospital stay
(Papoulidis et al., 2011). However, available data are few and more
large-scale clinical trials are still lacking to conﬁrm this beneﬁ-
cial effect of vitamin C (Rasoli et al., 2011). It is noteworthy that
vitamin C could also abrogate the beneﬁcial effects of ischemic
preconditioning, a phenomenon induced by a series of brief sub-
lethal episodes of ischemia and reperfusion prior to a potentially
lethal episode of ischemia that renders the heart more resistant to
myocardial infarction (Tsovolas et al., 2008). Likely, the precon-
ditioning is abolished due to an abrogation of ROS production, a
phenomenon that otherwise could give rise to a survival response
by the antioxidant defense system.Ascorbate preloading,among its
many effects, has been shown to down-regulate p47phox and thus
attenuate NADPH oxidase-derived ROS production (Wu et al.,
2007).
n−3 Polyunsaturated fatty acids
It has been demonstrated the electrophysiological effects of n−3
PUFAaccount for their acute antiarrhythmicpotential,beingmore
remarkable with DHA and EPA as compared with α-linolenic acid
(Milberg et al., 2011). However, while the anti-inﬂammatory or
antiarrhythmic effects of n−3 PUFA may decrease the risk of
postoperative AF, interventional studies have yielded conﬂicting
results. Thus, at present there exists a controversy respect the ben-
eﬁcial effects of n−3PUFA in the prevention of AF recurrence after
direct cardioversion (Kumar et al., 2011; Nodari et al., 2011; Oza-
ydin et al., 2011). Although the mechanism of postoperative AF is
based on acute factors, such as inﬂammation and oxidative stress,
the vulnerability of myocardial tissue will be dependent on the
tissue redox status at the time of receiving the oxidative challenge.
Likely, vitamins C and E supplementation contributes with a rein-
forcement of the non-enzymatic antioxidant system. However, the
antioxidant enzymes also could be a target of interventions aimed
to induce up-regulation of their activities, thus further enhanc-
ing the antioxidant potential against the unavoidable ROS burst
during the tissue reperfusion. Low to moderate ROS production
is thought to lead to a survival response mediated by Nrf2. In
addition to repeated short-term ischemia–reperfusion cycles, or
through pharmacological agents, this response could be induced
by n−3 PUFA supplementation. Due to their highly unsaturated
chemical structure, n−3 PUFA are highly prone to peroxidation,
which proceeds through both enzymatic and non-enzymatic path-
ways. Therefore, these compounds suitable to create a condition of
increased ROS production regulated by the administered dose. An
appropriate dose to cause increase of ROS concentration enough
to activate Nrf2 pathway, but not cell death pathways, will elicit a
survival response rendering the myocardial tissue more resistant
to a subsequent ROS exposure and derived consequences, such
as postoperative AF. In support of this view, experimental studies
performed in heart of rats supplemented with n−3 PUFA rich
ﬁsh oil demonstrated a signiﬁcant enhancement of the expres-
sion of antioxidant enzymes (Jahangiri et al., 2006). Some studies
aimed to the prevention of postoperative AF have demonstrated
a signiﬁcant reduction of its incidence in patients subjected to
cardiac surgery with extracorporeal circulation (Calò et al., 2005;
Mariscalco et al., 2010; Castillo et al., 2011). However, other stud-
ies found no evidence of a beneﬁcial effect of treatment with
n−3 PUFA on these patients (Heidarsdottir et al., 2010; Saravanan
et al., 2010). It should be mentioned a meta-analysis that did not
demonstrate signiﬁcant effects of n−3 PUFA supplementation on
AF prevention (Liu et al., 2011), although these compounds may
favorably affect atrial remodeling in AF (Korantzopoulos et al.,
2005). Likely, this controversy arises from the nature of n−3 PUFA
administered to patients, having a key role the 1/2= EPA/DHA
ratio. In fact, the three successful studies in diminishing the inci-
dence of the arrhythmia administered n−3 PUFA nearly in this
ratio. In turn, the unsuccessful studies showed a higher EPA/DHA
ratio. This view is supported by a recent study reporting a trend
toward a beneﬁt from n−3 PUFA supplementation when the
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EPA/DHA ratio is 1/2 (Benedetto et al., 2011). However, more
mechanistic studies to ascertain themolecular basis of these effects
are still lacking.
HYPOTHESIS FOR A NOVEL THERAPEUTIC STRATEGY BASED
ON MODULATION OF THE ANTIOXIDANT SYSTEM
Cumulated evidence, previously discussed, leads to support the
view for a potential role of n−3 PUFA and vitamins C and E
in protecting the myocardial damage derived from reperfusion
following extracorporeal circulation. This hypothesis is based on
two-step regime applied from a week before surgery, composed
of (Zimmer et al., 2003) an oxidative stress stimulus to promote
up-regulation of the endogenous enzymatic antioxidant defense
system, through n−3 PUFA supplementation, followed by (Gille-
spie et al., 2005) a reinforcement of the non-enzymatic antioxidant
component through supplements of vitamins C and E (Rodrigo
et al., 2007b, 2008). Under these conditions, it should be expected
a decreased vulnerability of cardiac tissue to the oxidative chal-
lenge occurring because of the ischemia–reperfusion event proper
of this surgery. Consequently, taking into account the role of ROS
and RNS in the development of postoperative AF, this antioxidant
supplementation could reduce the incidence of the arrhythmia.
Although the available clinical trial are controversial to support
this hypothesis, the latter should be complemented with the need
to administer n−3 PUFA in a 1/2= EPA/DHA ratio, since all the
studies using this protocol found a successful prevention of post-
operativeAF. In addition, an independent effect of ascorbate could
enhance this cardioprotection. This hypothesis is summarized in
Figure 2.
CONCLUDING REMARKS AND PERSPECTIVES
Postoperative AF is a common complication, particularly follow-
ing cardiac surgery with extracorporeal circulation. It increases
the incidence of other complications, hospital, and healthcare
costs. Although the precise pathophysiological mechanisms of
this arrhythmia related to cardiac surgery are poorly under-
stood, oxidative stress and inﬂammation in atrial tissue may
be causally related to AF. High ROS levels could give rise to
pathological effects of oxidative stress characterized by oxidative
damage, resulting in cell dysfunction, apoptosis, and/or necro-
sis. Conversely, at lower concentrations, local targeted produc-
tion of ROS serves as a second messenger system that transmits
biological information by highly speciﬁc modulation of intra-
cellular signaling molecules, enzymes, and proteins. The latter
process includes an adaptive response to enhance antioxidant
defenses, mainly by up-regulating antioxidant enzymes expres-
sion and/or anti-apoptotic pathways. The reduction of ROS, with
hydroxyl radical scavengers, in theheart attenuates the rate changes
induced by hypoxia and reoxygenation, and also decreases the
burst ﬁring incidence. To date, prophylactic therapies for post-
operative AF are largely empirical and suboptimal. Despite the
uncertainty of the beneﬁcial effects provided by clinical studies,
optimal EPA/DHA ratio has been recently argued to explain the
preventive effects of n−3 PUFA against postoperative AF. The
FIGURE 2 | Mechanism supporting a novel strategy for the
protective effect of n−3 PUFA and antioxidant vitamin
administration against postoperative atrial fibrillation in patients
subjected to cardiac surgery with extracorporeal circulation. EPA,
eicosapentaenoic acid; DHA, docosahexaenoic acid; PLC,
Phospholipase C; Tx A2, Thromboxane A2; IP3, Inositol trisphosphate;
Ca++, cytosolic calcium. Adapted from Rodrigo et al. (2008) with
permission.
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hypothesis for a novel therapeutic strategy based on the para-
digm that a reinforcement of the antioxidant systembefore cardiac
surgery should decrease the vulnerability of myocardium to the
oxidative challenges is presented. Low to moderate ROS expo-
sure can be created by n−3 PUFA supplementation, giving rise
to up-regulation of antioxidant enzymes in cardiac tissue. Addi-
tionally, vitamins C and E are capable of the reinforcement of
non-enzymatic antioxidant defenses. The intervention supported
by this hypothesis would be safe, low cost, and readily avail-
able, and the systemic effects of this treatment make possible
its use in other clinical settings related to ischemia–reperfusion,
such as percutaneous coronary interventions following acute
myocardial infarction or transplantation of live organ donation.
The present study should encourage the design of clinical tri-
als aimed to offer new therapeutic opportunities to all these
patients.
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